Medicare Enrolled
Dr. Mark Kachadurian, DO
Neurology · Farmington Hills, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kachadurian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kachadurian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kachadurian
Dr. Mark Kachadurian is a neurology specialist in Farmington Hills, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kachadurian performed 11,600 Medicare services across 809 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kachadurian received a total of $334,328 from 83 pharmaceutical and/or device companies across 1749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kachadurian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 4% volume in MI
$334,328 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,600
Medicare services
Top 4% in MI for neurology
809
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~552 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
10,300 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
690 | $91 | $155 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
106 | $91 | $234 |
| New patient office visit, complex (60-74 min) | 98 | $157 | $290 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
91 | $358 | $870 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 55 | $63 | $165 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
47 | $27 | $75 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
47 | $28 | $75 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
33 | $156 | $390 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
27 | $136 | $370 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $139 | $280 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
20 | $102 | $290 |
| Auditory brainstem response test A test that measures the brain's response to sound to determine hearing thresholds. The results are interpreted and reported by a medical professional. |
18 | $92 | $241 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $66 | $128 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
15 | $97 | $235 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
13 | $169 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$334,328
Total received (2018-2024)
Avg $47,761/year across 7 years
Top 3% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,749
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$305,154 (91.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,263 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,911 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,211
2023
$9,483
2022
$45,534
2021
$54,019
2020
$51,871
2019
$78,746
2018
$85,464
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,822
UCB, Inc.
$479
Novartis Pharmaceuticals Corporation
$408
Lundbeck LLC
$373
Neurocrine Biosciences, Inc.
$230
Biogen, Inc.
$191
PFIZER INC.
$184
Sumitomo Pharma America, Inc.
$166
Amgen Inc.
$116
Alnylam Pharmaceuticals Inc.
$115
Lilly USA, LLC
$111
Takeda Pharmaceuticals U.S.A., Inc.
$106
Alexion Pharmaceuticals, Inc.
$104
CSL Behring
$82
Kyowa Kirin, Inc.
$75
Celgene Corporation
$72
Otsuka America Pharmaceutical, Inc.
$69
SK Life Science, Inc.
$64
CATALYST PHARMACEUTICALS, INC.
$62
TG Therapeutics, Inc.
$42
ARGENX US, INC.
$41
ACADIA Pharmaceuticals Inc
$41
JAZZ PHARMACEUTICALS INC.
$38
Genentech USA, Inc.
$36
Grifols USA, LLC
$27
Vanda Pharmaceuticals Inc.
$27
Mallinckrodt Hospital Products Inc.
$26
LivaNova USA, Inc.
$21
Eisai Inc.
$20
HOSPIRA, INC.
$17
Teva Pharmaceuticals USA, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Aucta Pharmaceuticals, Inc.
$14
Top 3 companies account for 72.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$108,468
Amgen Inc.
$80,396
Teva Pharmaceuticals USA, Inc.
$48,736
ABBVIE INC.
$38,446
AbbVie Inc.
$16,267
Allergan, Inc.
$12,443
Biohaven Pharmaceuticals, Inc.
$9,431
Biohaven Pharmaceutical Holding Company Ltd.
$2,875
Novartis Pharmaceuticals Corporation
$2,384
Avanir Pharmaceuticals, Inc.
$1,471
UCB, Inc.
$1,363
Biogen, Inc.
$1,107
EMD Serono, Inc.
$952
Celgene Corporation
$882
Neurocrine Biosciences, Inc.
$674
Promius Pharma LLC
$628
GENZYME CORPORATION
$624
Lundbeck LLC
$528
PFIZER INC.
$492
Alexion Pharmaceuticals, Inc.
$389
Sumitomo Pharma America, Inc.
$341
CSL Behring
$338
ACADIA Pharmaceuticals Inc
$281
US WorldMeds, LLC
$252
Alnylam Pharmaceuticals Inc.
$246
Eisai Inc.
$230
Neurelis, Inc.
$225
Adamas Pharmaceuticals, Inc.
$217
Janssen Pharmaceuticals, Inc
$197
Allergan Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$191
SK Life Science, Inc.
$185
Grifols USA, LLC
$163
Kyowa Kirin, Inc.
$137
Bausch Health US, LLC
$125
Supernus Pharmaceuticals, Inc.
$120
IMPEL PHARMACEUTICALS INC.
$120
EISAI INC.
$120
TG THERAPEUTICS, INC.
$115
Sunovion Pharmaceuticals Inc.
$113
Horizon Therapeutics plc
$104
CATALYST PHARMACEUTICALS, INC.
$89
MDD US Operations, LLC
$70
Merz Pharmaceuticals, LLC
$70
JAZZ PHARMACEUTICALS INC.
$69
Otsuka America Pharmaceutical, Inc.
$69
Amneal Pharmaceuticals LLC
$68
Cala Health, Inc.
$67
Strongbridge US INC.
$66
Genentech USA, Inc.
$65
ARGENX US, INC.
$64
Acorda Therapeutics, Inc
$62
Akcea Therapeutics, Inc.
$62
AstraZeneca Pharmaceuticals LP
$58
Medtronic USA, Inc.
$58
Catalyst Pharmaceuticals, Inc.
$53
Mallinckrodt Hospital Products Inc.
$52
Zogenix Inc.
$50
Corium, LLC
$50
Bayer HealthCare Pharmaceuticals Inc.
$49
TG Therapeutics, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$41
Greenwich Biosciences, Inc.
$38
Mylan Pharmaceuticals Inc.
$38
LivaNova USA, Inc.
$36
Kedrion Biopharma Inc.
$33
ASSERTIO THERAPEUTICS, Inc.
$33
Banner Life Sciences, LLC
$32
Vanda Pharmaceuticals Inc.
$27
BANNER LIFE SCIENCES, LLC
$27
Xeris Pharmaceuticals, Inc.
$23
AQUESTIVE THERAPEUTICS, INC.
$23
Scilex Pharmaceuticals Inc.
$21
Mallinckrodt LLC
$20
GE Healthcare
$18
Mitsubishi Tanabe Pharma America, Inc.
$17
HOSPIRA, INC.
$17
Validus Pharmaceuticals LLC
$16
AbbVie, Inc.
$15
Aucta Pharmaceuticals, Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$13
Egalet US Inc
$12
Zyla Life Sciences
$11
Top 3 companies account for 71.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BAVENCIO · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · COPAXONE · Cambia · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Equetro · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gammaked · Gamunex-C · Glatiramer Acetate · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PONVORY · Ponvory · Privigen · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Soliris · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · XARELTO · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in MI.
Geographic Context
Neurologists within 10 mi
356
Per 100K population
28.0
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kachadurian is a mixed practice specialist, with above-average Medicare volume (top 4% in MI), with speaking/promotional industry engagement in the top 3% of MI peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kachadurian experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kachadurian performed 10,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kachadurian receive payments from pharmaceutical companies?
Yes. Dr. Kachadurian received a total of $334,328 from 83 companies across 1,749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kachadurian's costs compare to other neurologists in Farmington Hills?
Dr. Kachadurian's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kachadurian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Farmington Hills
Browse neurologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology